By 2026, Tong Ren Tang will focus on developing the supermarket channel as one of the key directions.

Tianjin Pharmaceutical Group recently stated at an investor offline event in 2026 that the supermarket channel is a rapidly growing channel. Many of the company's products are not well positioned and invested in the supermarket channel. For example, glucosamine dominates the VDS market for pharmaceuticals, but compared with top supermarket brands, there is still a significant gap. Probiotics are also in a similar situation. In 2026, the company will focus on the supermarket channel as one of its key areas of development, aiming to achieve breakthroughs through innovation, differentiated products, and refined operations.